Imerys S.A.

Imerys S.A.

IMYSF
Imerys S.A.US flagOther OTC
24.99
USD
- -
- -
2.11BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
48.94
48.44
51.55
52.91
54.41
57.93
55.06
46.23
43.27
50.62
44.87
42.62
40.01
42.68
Basic EPS, GAAP
3.2
3.57
0.86
3.72
4.66
7.06
1.53
0.37
2.84
2.8
0.61
-1.12
-4.83
-1.13
Free Cash Flow per Basic Share
6.13
5.47
6.87
8.05
3.55
3.45
2.57
3.36
2.14
0.54
2.61
-2.02
1.32
- -
Dividend per Share
1.55
1.61
1.67
1.75
1.88
2.12
2.18
0.21
1.26
1.63
3.86
1.38
1.46
- -
Book Value per Share
2.02
1.99
2.01
2.02
2.01
2.01
3.54
2.07
2.01
2.01
2.01
2.01
2.01
0.89
Tangible Book Value per Share
15.07
17.04
11.8
14.71
5.53
10.51
9.2
6.38
9.37
14.73
11.65
12.52
10.63
12.53
Basic Weighted Avg Shares
76
76
79
79
79
79
79
82
85
85
85
85
85
84
Sales/Revenue/Turnover
3,698
3,688
4,087
4,165
4,299
4,590
4,354
3,798
3,665
4,282
3,794
3,605
3,384
3,606
Operating Margin (%)
11.38
12.08
12.9
13.85
12.04
3.58
8.03
7.83
9.07
9.25
6.65
6.94
5.64
6.5
Depreciation Expense
208
209
225
226
266
495
354
342
324
317
511
302
855
- -
Net Income, GAAP
242
272
68
293
368
560
121
30
240
237
51
-95
-409
-95
Effective Tax Rate (%)
29.08
30.13
44.9
32.55
28.25
- -
35.35
57.76
27.23
33.94
87.54
- -
- -
- -
Profit Margin (%)
6.54
7.36
1.67
7.03
8.56
12.19
2.78
0.79
6.55
5.54
1.35
-2.64
-12.08
-2.64
Working Capital
915
1,251
707
928
486
1,441
868
833
978
1,494
1,185
982
1,246
982
LT Debt
1,190
1,494
1,500
1,602
1,986
1,996
1,884
1,866
1,851
1,793
1,810
1,803
2,141
1,803
Total Equity
2,272
2,470
2,672
2,914
2,878
3,254
3,162
2,960
3,242
3,385
3,157
3,301
2,615
3,301
Return on Invested Capital (%)
8.42
8.12
6.68
7.91
6.86
- -
4.06
2.32
4.56
4.67
0.55
- -
- -
- -
Return on Capital (%)
17.47
18.7
5.19
14.97
15.47
- -
6.3
1.88
11.04
10.29
2.14
- -
- -
- -
Return on Common Equity (%)
81.41
178.51
43.99
183.92
231.28
351.73
55.19
13.37
141.32
139.61
30.19
-55.92
-240.61
-64.37

Capital Structure

FRC

in mil. unless spec.
Jun'24
Sep'24
Dec'24
ST Debt
600
- -
108
LT Borrowings
1,694
- -
1,693
LT Finance Leases
107
- -
110
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
85
- -
84
Market Capitalization
2,448
2,424
2,340

Working Capital

FRC

in mil. unless spec.
Jun'24
Sep'24
Dec'24
Total Current Assets
2,693
- -
1,966
Cash, Cash Equivalents & STI
1,167
- -
640
Accounts Receivable, Net
407
- -
364
Inventories
692
- -
725
Total Current Liabilities
1,551
- -
984
Payables & Accruals
- -
- -
- -
ST Debt
600
- -
108
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
0.26%
-1.81%
-20.78%
Free Cash Flow
-10.18%
-14.03%
-165.47%
Net Income, GAAP
91.55%
132.64%
330.32%
Sales/Revenue/Turnover
-1.52%
-1.84%
-6.14%
Total Cash Common Dividend
55.12%
122.66%
5.84%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
997
985
918
894
3,794
2024
926
993
855
832
3,605
2025
- -
- -
- -
- -
3,384

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
1.2
- -
0.45
- -
0.61
2024
0.82
0.86
-3.37
- -
-1.12
2025
- -
- -
- -
- -
-4.83

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
3.86
2024
- -
- -
- -
- -
1.38
2025
- -
- -
- -
- -
1.46

Company Description

MCPAPIChat
CEO
Alessandro Dazza
Full Time Employees
12,400
Sector
Basic Materials
Industry
Construction Materials
Address
43 Quai de Grenelle Paris France 75015
IPO Date
Dec 14, 2009
Website
imerys.com
Business
Imerys S.A. produces and processes industrial minerals for a broad range of applications worldwide. The company supplies performance minerals serving as additives for plastics, paints and coatings, filtration and life sciences, ceramics, and building products; specialty minerals functioning as processing aids for extreme conditions in refractory, foundry, abrasives, and building chemistry; graphite and carbon minerals targeting energy transition and mobile energy markets; and specific minerals including andalusite, bentonite, calcium carbonate, carbon black, diatomite, graphite, lithium, mullite, perlite, quartz, talc, zeolite, zirconia, and wollastonite. Imerys operates across three main business areas: Performance Minerals, Solutions for Refractory, Abrasives and Construction, and Solutions for Energy Transition, with end markets encompassing abrasives, advanced ceramics, animal care, batteries and fuel cells, building materials, ceramics, component manufacturing, cosmetics and personal care, crop production, food and beverage, health, pharmaceuticals and biotechnology, infrastructure and utilities, investment casting, pulp and packaging, and rubber. Founded in 1880 and headquartered in Paris, France, the company maintains operations in over 40 countries with approximately 230 industrial sites across the Americas, Europe Middle East Africa, and Asia-Pacific, including major offices in Roswell, Georgia (North America), Kifisia, Greece, Shanghai, China, and Nagpur, India; Imerys functions as a subsidiary of Belgian Securities BV. Recent developments include the completion of the acquisition of Chemviron’s European diatomite and perlite business in early 2025, incorporating assets in France and Italy that generate around €50 million in revenue and add 130 employees to bolster capabilities in filtration and life sciences for food, beverage, and pharmaceuticals markets; a September 2025 distribution partnership with LBB Specialties designating the latter as preferred distributor for Imerys' ImerCare portfolio in personal care and minerals for food and nutrition across the United States, Canada, and Puerto Rico; and the prior divestiture of its High Temperature Solutions business to Platinum Equity in 2022 for €930 million alongside the sale of North American talc operations to Magris Resources in 2020-2021 amid litigation resolutions.

Company News

MCPAPIChat
  • Imerys S.A. (IMYSY) Shareholder/Analyst Call Transcript

  • Imerys S.A. (IMYSY) Q1 2026 Earnings Call Transcript

  • Amrize (NYSE:AMRZ) versus Imerys (OTCMKTS:IMYSF) Head to Head Contrast

  • Imerys S.A. (IMYSY) Q4 2025 Earnings Call Transcript

  • Imerys freezes UK lithium project to focus on France

  • Financial Analysis: Imerys (OTCMKTS:IMYSF) vs. Wienerberger (OTCMKTS:WBRBY)

  • Imerys (OTCMKTS:IMYSF) Shares Down 3.6% – Here’s What Happened

  • French satellite operator Eutelsat taps Imerys exec as next finance chief

  • Imerys S.A. (IMYSY) Q3 2025 Earnings Call Transcript

  • Imerys S.A. (IMYSF) Q2 2025 Earnings Call Transcript

  • Graphite Miners News For The Month Of June 2025

  • Graphite Miners News For The Month Of May 2025

  • Imerys: Tough Times For Talc

  • Graphite Miners News For The Month Of April 2025

  • Imerys S.A. (IMYSF) Q1 2025 Earnings Call Transcript

  • Imerys S.A. (IMYSF) Q4 2024 Earnings Call Transcript

  • Nucleating & Clarifying Agents Market Outlook 2024-2029, with Profiles for Milliken, Clariant, Adeka, BASF, Avient, Imerys, New Japan Chemical Co, GCH Technology Co, Plastiblends India and More

  • Imerys S.A. (IMYSF) Q3 2024 Earnings Call Transcript

  • Imerys recognizes CynerSorb® as a sustainable solution and Pioneer Product for the Renewable Diesel market

  • Imerys S.A. (IMYSF) Q2 2024 Earnings Call Transcript